2536
J. Duran et al. / Tetrahedron: Asymmetry 14 (2003) 2529–2538
solution of (−)-menthone (3.84 mL, 20.0 mmol) in
anhydrous DMSO (5 mL) was gradually added over 10
min, the reaction mixture was then protected from light
and stirred at rt for 24 h. The reaction mixture was
poured on ice/water (80 mL) and the aqueous phase
extracted with diethyl ether (3×40 mL). The organic
phase was washed with water (2×20 mL), dried with
magnesium sulphate, filtered, evaporated to dryness,
and distilled (70–75°C, 0.1 Torr) to yield liquid
(1S,4S,7R)-4-isopropyl-7-methyl-1-oxa-spiro[2.5]octane
2 of purity >97% by GLC (2.69 g, 80%). 1H NMR
was slowly added to an ice-cold solution of a commer-
cial mixture of NaNH2 and (C6H5)3PCH3Br (14.47 g,
34.2 mmol) in anhydrous THF (15 mL), with stirring
under a nitrogen atmosphere. After 3 h, aqueous 25%
NaOH (15 mL) was added. The aqueous phase was
extracted with diethyl ether (3×10 mL). The organic
phase was washed with deoxygenated saturated ammo-
nium chloride aqueous solution until neutrality and
deoxygenated water (15 mL), dried with magnesium
sulphate, filtered and evaporated to dryness at 35°C.
Purification of the crude product by flash chromatogra-
phy (hexane) afforded liquid (1S,4R)-1-isopropyl-4-
methyl-2-methylene-cyclohexane 5 of purity >99% by
3
(CDCl3 sol.): l 0.80 (d, 3H, H10, J=6.8 Hz); 0.90 (d,
3
3
3H, H11, J=6.8 Hz); 0.91 (d, 3H, H9, J=6.5 Hz);
2
1
1.0-1.9 (m, 9H, H3-H8); 2.47 (d, 1H, H1, J=4.5 Hz);
GC (3.10 g, 88%). H NMR (CDCl3 sol.): l 0.7–0.9 (m,
2
2.90 (d, 1H, H1%, J=4.5 Hz). 13C{1H} NMR (CDCl3
9H, H9-H11); 1.0–1.7 (m, 7H, H3,H4-H7); 1.89 (psoct,
3
2
sol.): l 18.61 (s, C9); 21.83 (s, C10); 22.31 (s, CH11);
24.38 (s, C5); 25.88 (s, C8); 30.61 (s, C4); 33.94 (s, C6);
43.41 (s, C3); 44.81 (s, C7); 51.88 (s, C1); 61.05 (s, C2).).
MS: m/e 168 (M+, 5%); 153 (M+−15, 100%); 125 (M+−
43, 65%); 95 (75%); 81 (85%). [h]2D0=+7.7 (c 0.015,
CH2Cl2).
1H, H8, J:6.7 Hz); 2.28 (dd, 1H, H3%, J=11.9 Hz,
3J=3.6 Hz); 4.58 (br.s, 1H, H1); 4.70 (br.s, 1H, H1%).
13C{1H} NMR (CDCl3 sol.): l 18.98 (s, C9); 21.38 (s,
C10); 22.09 (s, CH11); 27.06 (s, C8); 27.37 (s, C5); 33.37
(s, C6); 33.99 (s, C4); 44.40 (s, C3); 49.36 (s, C7); 106.08
(s, C1); 151.16 (s, C2). IR (KBr): loop (ꢁCH2), 890 cm−1;
w(CꢁCH2), 1644 cm−1; w(ꢁCH2), 3086 cm−1.
Step
2.
(1S,4S,7R)-4-isopropyl-7-methyl-1-oxa-
spiro[2.5]octane 2 (200 mg, 1.19 mmol) was slowly
added to an ice-cold solution of potassium
diphenylphosphide (0.5 M in tetrahydrofuran, 12.7 mL,
6.38 mmol), while stirring under a nitrogen atmosphere.
The reaction mixture was then vigorously stirred at rt.
After 3 h, deoxygenated methanol (3 mL), deoxy-
genated saturated ammonium chloride aqueous solu-
tion (3 mL), and deoxygenated water (5 mL) were
consecutively added to the reaction mixture. The
aqueous phase was extracted with diethyl ether (3×15
mL). The organic phase was washed with water (15
mL), dried with magnesium sulphate, filtered and evap-
orated to dryness. Purification of the crude product by
flash chromatography (hexane/ethyl acetate: 9/1)
afforded (1S,2S,5R)-1-diphenylphosphinomethyl-2-iso-
propyl-5-methyl-cyclohexanol 3 as an oil of purity
>99% by NMR (334.7 mg, 76%). 1H NMR (CDCl3
sol.): l 0.7–1.0 (m, 9H, H9-H11); 1.0-2.0 (m, 8H, H3-H6,
Step 2. A solution of m-CPBA (4.08 g, 23.7 mmol) in
CH2Cl2 (25 mL) was added to a mixture containing
(1S,4R)-1-isopropyl-4-methyl-2-methylene-cyclohexane
5 (1.08 g, 7.09 mmol), CH2Cl2 (15 mL) and aqueous
NaHCO3 (15 mL, 5%). The reaction mixture was pro-
tected from light and stirred for 4 h. The aqueous phase
was extracted with CH2Cl2 (2×10 mL). The organic
phase was washed with NaOH 2 M (2×20 mL) and
water (15 mL), dried with magnesium sulphate, filtered,
evaporated to dryness at 35°C and distilled (70–75°C,
0.1 Torr) to yield a liquid mixture of oxiranes 2 and 4
1
(1.04 g, 87.5%, 55:45). Data for 4: H NMR (CDCl3
3
sol.): l 0.78 (d, 3H, H10, J=6.8 Hz); 0.91 (d, 3H, H11,
3
3J=6.8 Hz); 0.95 (d, 3H, H9, J=6.7 Hz); 0.9–1.9 (m,
2
9H, H3-H8); 2.49 (d, 1H, H1, J=4.8 Hz); 2.75 (d, 1H,
2
H1%, J=4.8 Hz). 13C{1H} NMR (CDCl3 sol.): l 19.53
(s, C9); 21.67 (s, C10); 22.85 (s, CH11); 24.01 (s, C8);
24.90 (s, C5); 31.84 (s, C6); 32.82 (s, C4); 42.80 (s, C3);
46.03 (s, C7); 51.86 (s, C1); 60.22 (s, C2).
2
H8, OH); 2.17 (m, 1H, H7); 2.43 (dd, 1H, H1, J=14.4
Hz, 2JHꢀP=3.4 Hz); 2.69 (dd, 1H, H1%, 2J=14.4 Hz,
2JHꢀP=4.4 Hz); 7.2–7.8 (m, 10H, Har). 13C{1H} NMR
(CDCl3 sol.): l 18.05 (s, C9); 20.79 (s, C5); 22.17 (s,
C10); 23.35 (s, C11); 25.91 (s, C8); 28.02 (s, C4); 34.97 (s,
6.3. Preparation of trans-P,P-bis-{m-chlorocarbonyl-
[(1S,2S,5R)-1-diphenylphosphinomethyl-2-isopropyl-
5-methyl-cyclohexanol-P]rhodium(I)} 6
1
3
C6); 41.86 (d, C1, JCꢀP=15.5 Hz); 49.33 (d, C3, JCꢀP
=
3
12.1 Hz); 49.52 (d, C7, JCꢀP=4.7 Hz); 75.51 (d, C2,
2JCꢀP=13.7 Hz); 127–140 (Car). 31P{1H} NMR (CDCl3
sol.): l −24.87 (s). MS: m/e 354 (M+, 15%); 333 (M+−
18, 5%); 199 (100%); 186 (60%). [h]2D5=−8.8 (c 0.012,
CH2Cl2).
Ligand 3 (98 mg, 0.26 mmol) in CH2Cl2 (5 mL) was
added to a solution of [Rh2Cl2(CO)4] (51 mg, 0.13
mmol) also in CH2Cl2 (5 mL). The reaction mixture
was stirred at rt for 24 h. The volume was reduced to 3
mL and the product precipitated by the addition of
ethyl ether. 68 mg of complex 6 were obtained, 50%
yield, as an orange solid. 1H NMR (CDCl3 sol.): l
0.5–1.1 (m, 9H, H9-H11); 1.1–2.3 (m, 8H, H3-H6, H8);
6.2. Preparation of mixtures of (1S,4S,7R)-4-isopropyl-
7-methyl-1-oxa-spiro[2.5]octane 2 and (1R,4S,7R)-4-iso-
propyl-7-methyl-1-oxa-spiro[2.5]octane 4
2
2
2.65 (td, 1H, H1, J=14.2 Hz, JHꢀP=14.2 Hz, J=2.6
2
2
Method A. The procedure described to obtain epoxide 2
from (−)-menthone using (CH3)3SI as reactant pro-
duced a mixture of oxiranes 2 and 4 (95:5) in an 80%
yield.
Hz); 3.08 (dd, 1H, H1%, J=14.2 Hz, JHꢀP=8.0 Hz);
3.67 (br.s, 1H, OH) 7.3–8.2 (m, 10H, Har). 13C{1H}
NMR (CDCl3 sol.): l 18.77 (s, C9); 21.54 (s, C5); 22.25
(s, C10); 23.93 (s, C11); 26.73 (s, C8); 28.38 (s, C4); 34.54
(s, C6); 40.93 (d, C1, 1JCꢀP=25.2 Hz); 48.57 (d, C3,
3
Method B. Step 1. (−)-Menthone (4 mL, 23.15 mmol)
3JCꢀP=9.0 Hz); 49.71 (d, C7, JCꢀP=5.2 Hz); 88.40 (s,